SEC Form 4 · accession 0001127602-18-010964

Elevance Health, Inc. · ELV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — SVP, Chief Accounting Officer

Period of report

Mar 7, 2018

Accepted (ET)

Mar 9, 2018 · 4:41 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001156039

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Mar 7, 2018	M	217	$146.93	A	2,132	D
Common Stock	Mar 7, 2018	M	405	$131.80	A	2,537	D
Common Stock	Mar 7, 2018	M	357	$166.97	A	2,894	D
Common Stock	Mar 7, 2018	S	979	$231.99	D	1,915	D
Common Stock	Mar 7, 2018	S	987	$231.82	D	928	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (Right to Buy)^F1	$146.93	Mar 7, 2018	M	217	D	—	Mar 2, 2025	Common Stock	217	0	D
Employee Stock Option (Right to Buy)^F2	$131.80	Mar 7, 2018	M	405	D	—	Mar 1, 2026	Common Stock	405	812	D
Employee Stock Option (Right to Buy)^F3	$166.97	Mar 7, 2018	M	357	D	—	Mar 1, 2027	Common Stock	357	1,428	D

F1The option represents a right to purchase a total of 1,301 shares, became is exercisable in six semi-annual installments, with one installment of 216 shares and five installments of 217 shares each, beginning on September 2, 2015, which is the six-month anniversary of the option grant date.
F2The option represents a right to purchase a total of 2,432 shares, and is exercisable in six semi-annual installments, with four installments of 405 shares each and two installments of 406 shares each, beginning on September 1, 2016, which is the six-month anniversary of the option grant date.
F3The option represents a right to purchase a total of 2,141 shares, and is exercisable in six semi-annual installments, with one installment of 356 shares and five installments of 357 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date.